Literature DB >> 15182181

Dual functional roles of ATP in the human mitochondrial malic enzyme.

Wen-Chi Hsu1, Hui-Chih Hung, Liang Tong, Gu-Gang Chang.   

Abstract

Human mitochondrial malic enzyme is a regulatory enzyme with ATP as an inhibitor. Structural studies reveal that the enzyme has two ATP-binding sites, one at the NAD(+)-binding site in the active center and the other at the exo site in the tetramer interface. Inhibition of the enzyme activity is due to the competition between ATP and NAD(+) for the nucleotide-binding site at the active center with an inhibition constant of 81 microM. Binding of the ATP molecule at the exo site, on the other hand, is important for the maintenance of the quaternary structural integrity. The enzyme exists in solution at neutral pH and at equilibrium of the dimer and tetramer with a dissociation constant (K(TD)) of 0.67 microM. ATP, at a physiological concentration, shifts the equilibrium toward tetramer and decreases the K(TD) by many orders of magnitude. Mutation of a single residue Arg542 at the tetrameric interfacial exo site resulted in dimeric mutants. ATP thus has dual functional roles in the mitochondrial malic enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182181     DOI: 10.1021/bi049600r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  NAD-preferring malic enzyme: localization, regulation and its potential role in herring (Clupea harengus) sperm cells.

Authors:  Natalia Niedźwiecka; Jadwiga Gronczewska; Edward F Skorkowski
Journal:  Fish Physiol Biochem       Date:  2016-09-14       Impact factor: 2.794

2.  Arabidopsis thaliana NADP-malic enzyme isoforms: high degree of identity but clearly distinct properties.

Authors:  Mariel C Gerrard Wheeler; Cintia L Arias; Marcos A Tronconi; Verónica G Maurino; Carlos S Andreo; María F Drincovitch
Journal:  Plant Mol Biol       Date:  2008-06       Impact factor: 4.076

3.  Metal ions stabilize a dimeric molten globule state between the open and closed forms of malic enzyme.

Authors:  Hui-Chuan Chang; Liang-Yu Chen; Yi-Hang Lu; Meng-Ying Li; Yu-Hou Chen; Chao-Hsiung Lin; Gu-Gang Chang
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Human mitochondrial NAD(P)(+)-dependent malic enzyme participates in cutaneous melanoma progression and invasion.

Authors:  Yung-Lung Chang; Hong-Wei Gao; Chien-Ping Chiang; Wei-Ming Wang; Shih-Ming Huang; Chien-Fen Ku; Guang-Yaw Liu; Hui-Chih Hung
Journal:  J Invest Dermatol       Date:  2014-09-09       Impact factor: 8.551

5.  Functional roles of the tetramer organization of malic enzyme.

Authors:  Ju-Yi Hsieh; Shao-Hung Chen; Hui-Chih Hung
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

6.  Determinants of nucleotide-binding selectivity of malic enzyme.

Authors:  Ju-Yi Hsieh; Meng-Chun Chen; Hui-Chih Hung
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

7.  Mitochondrial NAD+-dependent malic enzyme from Anopheles stephensi: a possible novel target for malaria mosquito control.

Authors:  Jennifer Pon; Eleonora Napoli; Shirley Luckhart; Cecilia Giulivi
Journal:  Malar J       Date:  2011-10-26       Impact factor: 2.979

8.  A small-molecule inhibitor suppresses the tumor-associated mitochondrial NAD(P)+-dependent malic enzyme (ME2) and induces cellular senescence.

Authors:  Ju-Yi Hsieh; Shao-Yu Li; Wen-Chen Tsai; Jyung-Hurng Liu; Chih-Li Lin; Guang-Yaw Liu; Hui-Chih Hung
Journal:  Oncotarget       Date:  2015-08-21

9.  Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response.

Authors:  Wei-Ven Tee; Enrico Guarnera; Igor N Berezovsky
Journal:  PLoS Comput Biol       Date:  2018-06-18       Impact factor: 4.475

10.  Fumarate analogs act as allosteric inhibitors of the human mitochondrial NAD(P)+-dependent malic enzyme.

Authors:  Ju-Yi Hsieh; Jyung-Hurng Liu; Pai-Chun Yang; Chi-Li Lin; Guang-Yaw Liu; Hui-Chih Hung
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.